Cerebras Launches IPO Roadshow at $26.6B Valuation, $3.5B Raise (May 4, 2026)

Cerebras Systems on May 4, 2026 filed an amended S-1 with the U.S. Securities and Exchange Commission to launch its IPO roadshow, setting a price band of $115–$125 per share, offering 28 million Class A shares, and targeting a fully-diluted valuation of up to $26.6 billion — roughly 20% above its February private round and one of the largest U.S. tech IPOs of 2026.

What Happened

The Sunnyvale-based AI chip maker had originally filed for its second IPO attempt in April 2026 at a working valuation of $22–$25 billion. The amended prospectus filed Monday formalizes the deal: 28 million shares at $115–$125 each, raising up to $3.5 billion, with the listing planned for the Nasdaq Global Select Market under the ticker CBRS. According to the filing and a Reuters report, the offering is expected to price on Tuesday, May 13, 2026, with trading beginning the following day.

The book is being run by an unusually large syndicate, reflecting both deal size and the policy sensitivity of putting an AI-chip alternative to Nvidia on the public market. Morgan Stanley, Citigroup, Barclays and UBS Investment Bank are joint lead book-running managers, with Mizuho and TD Cowen as additional bookrunners and Needham & Company, Craig-Hallum, Wedbush, Rosenblatt, Academy Securities, Crédit Agricole CIB, MUFG and First Citizens Capital Securities as co-managers.

Key Details

• $26.6B valuation, $3.5B raise: 28 million shares at $115–$125 a share, up from a working $22–$25 billion in the original April S-1.
• Premium to last private round: Cerebras' February 2026 secondary round, backed by AMD among others, valued the company at roughly $23 billion — the IPO band represents about a 15–20% step-up.
• Ticker CBRS on Nasdaq: Class A common stock will list on the Nasdaq Global Select Market.
• Pricing date May 13, 2026: The roadshow runs through the week of May 12, with pricing on May 13 and trading expected to begin May 14.
• Second attempt: Cerebras pulled an earlier IPO filing in October 2024 amid CFIUS scrutiny over its concentration of revenue from G42 in the United Arab Emirates; the new filing reflects a CFIUS-cleared cap table.
• OpenAI relationship: The S-1 discloses a multi-year inference deal with OpenAI worth roughly $20 billion through the end of the decade — disclosed in the April filing and reaffirmed in the amended prospectus.

What Developers and Users Are Saying

Reaction across Hacker News and r/MachineLearning has been mixed. The most-upvoted HN thread on the original April filing applauded Cerebras for shipping a wafer-scale alternative to Nvidia at all, but commenters flagged the customer concentration risk — G42 and OpenAI together account for the majority of disclosed forward bookings. On X, Stanford researcher and Together AI co-founder Percy Liang reposted the news with a short comment that Cerebras' inference latency benchmarks remain the headline reason customers are signing on. Several semiconductor analysts at Bernstein and Raymond James have published notes calling the $26.6B valuation "aggressive but defensible" given the OpenAI commit, with bull-case price targets above $150.

What This Means for Developers

Public-company status will force Cerebras to disclose far more about its WSE-3 cluster economics, performance and customer pipeline than it does today, which should make build-vs-buy decisions for inference workloads easier across the industry. For teams already running on Cerebras' Inference Cloud — the API priced from $0.10 per million tokens for Llama-class models — there is no immediate product change, but the IPO is expected to fund a meaningful expansion of capacity and developer tooling. For Nvidia-shop developers, the more interesting signal is competitive: a credible, publicly-traded inference alternative makes it easier to negotiate H100/H200/B200 capacity and pricing.

What's Next

The roadshow runs through the week of May 12, 2026, with pricing scheduled for May 13 after market close and shares expected to begin trading under CBRS on May 14. Watch for the final prospectus, the green-shoe (over-allotment) decision, and any further CFIUS-related disclosures. If priced at the midpoint of the range, Cerebras would become the most valuable AI-hardware IPO since Arm's 2023 listing and the second-largest U.S. tech IPO of 2026 to date.

Sources

• CNBC — AI chipmaker Cerebras targets $3.5 billion raise in IPO — primary reporting on the amended filing and price band.
• Tech Startups — Cerebras targets $3.5B IPO at $26.6B valuation — overview of the roadshow terms and underwriter syndicate.
• Yahoo Finance / Reuters — Cerebras Systems seeks up to $26.6B valuation — share count, ticker, listing exchange.
• Yahoo / proactiveinvestors — Cerebras IPO roadshow targets $115–$125 share price — price band and pricing date.
• Analytics Drift — What the $26.6B Nasdaq listing means for AI chips — analyst commentary on competitive positioning vs Nvidia.
• Cerebras.ai — official company site, product line and customer references.